US research roundup: Arxis, Cigna and Vylor
CI•Analysts reportedly revised ratings and price targets across several US-listed companies, including an upgrade for Arxis and new coverage of Vylor with an $85 target.
1. Selected analyst actions
RBC raised Arxis to outperform from sector perform and lifted its price target to $60 from $50. Piper Sandler raised Cigna’s target to $370 from $346. RBC initiated coverage of Vylor with an outperform rating and an $85 price target.
2. Other changes
The roundup also listed analyst actions for dozens of companies. Examples included New Street Research raising Amazon’s target to $385 from $350, and five firms cutting price targets for Nike.
